InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Oruka Therapeutics, Inc.

ORKA Clue Score22
United States Fiscal year ends December CIK 0000907654 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Arjun Agarwal
21 Sep 2026
Senior Vice President, Finance
Sold on a plan
533
$95.75
$51.03K
Arjun Agarwal
15 Sep 2026
Senior Vice President, Finance
Sold on a plan
560
$95.71
$53.60K
Arjun Agarwal
22 Jun 2026
Senior Vice President, Finance
Sold on a plan
699
$82.15
$57.42K
Arjun Agarwal
22 Jun 2026
Senior Vice President, Finance
Sold on a plan
888
$80.01
$71.05K
Arjun Agarwal
15 Jun 2026
Senior Vice President, Finance
Sold on a plan
395
$69.69
$27.53K
Carl Dambkowski
12 Jun 2026
Director
Sold on a plan
12,583
$70.11
$882.18K
Carl Dambkowski
11 Jun 2026
Director
Sold on a plan
22,417
$70.13
$1.57M
Show all 127 transactions →

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 110
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 4,378,602
History held since 2 Oct 2006